Synagis® Palivizumab
important safety informationprescribing informationcontact usen espaÑol
For Healthcare Professionals
 
 
 
 
 
You're not alone this RSV season. We can lend a Helping Hand(SM).
Please wash your hands before touching mine.

Sign up now for Helping HandSM, a program designed to support parents throughout RSV season. We'll send important reminders, share tips from parents who've been there, and help you learn more about protecting your baby from RSV.

You'll even get this FREE hangtag for your baby's stroller, along with other helpful items along the way.

To sign up, please complete the form below. If you're concerned about the privacy of your information, please see our Privacy Policy.

* Required fields

How Synagis Works
What Is RSV
Why Monthly Shots
Insurance Coverage
Resources & Support
Get a Helping Hand(SM)
 
 
 
Contact Info
 
*First Name
 
*Last Name
 
*Address 1
 
Address 2
 
*City
 
*State
*ZIP
 
*I would like to receive my Helping HandSM communications by:
E-mail (English)
Mail (English)
Mail (Spanish)
Why are we asking for this information?
Even if you prefer email, include your mailing address so we can send your free gifts by mail.
My Baby
 
Month/Year of child's birth:
(or expected date)
(Sample: mm/yyyy)
 
Number of weeks of pregnancy at birth?
 
Has your doctor talked to you about or recommended Synagis?
Yes
No
 
Has your baby received Synagis since June 2008?
(check all that apply)
Yes, in the hospital
Yes, at the doctor's office, clinic, etc.
No
 
Your baby's age and birth date will help us send infomation that is most relevant to you.
Reminders
I would like to receive monthly appointment reminder e-mails.
I would like monthly appointment reminder text messages sent to my cell phone (English-language only). By checking this box, I have read and agreed to the text message program Terms and Conditions.

Your plan’s standard text messaging rates may apply. For further information about the text messaging program, including information or possible charges and how to opt out of the program, please see the Terms and Conditions.
 
 
You’ll get customized monthly reminders about your baby’s next appointment.
Help Others
Thrive
I would like to know more about becoming an RSV advocate with the Thrive Network. The Thrive Network is exclusively funded by MedImmune and operated by Health Advocacy Strategies at MedImmune's direction.
I am also willing to participate in market research about RSV and related products and services.
*
By checking this box, I give permission for MedImmune and its agents to use the information I am submitting to provide me with information about RSV and products and services related to RSV. MedImmune respects your privacy. The information you provide will not be used for any other purposes or shared with any unrelated sources.
You can unsubscribe or update your information at any time.
 
Thrive is a voluntary network of parents who are interested in raising awareness about RSV. Representatives will contact you with further details.
If you are willing to participate, MedImmune and its agents will only use the information for internal research and will not sell or share your personal information with outside companies.
 
 
 
MedImmune

Important Safety Information

Synagis® (palivizumab) is indicated for the prevention of serious lung infections caused by respiratory syncytial virus (RSV) in children at high risk of RSV disease. Synagis is given as a shot, usually in the thigh muscle, each month during the RSV season. The first dose of Synagis should be given before RSV season begins. Children who develop an RSV infection while receiving Synagis should continue the monthly dosing schedule throughout the season. Synagis has been used in more than one million children in the U.S. since its introduction in 1998.

Very rare cases (<1 per 100,000 patients) of severe allergic reactions such as anaphylaxis and rare (<1 per 1,000 patients) hypersensitivity reactions have been reported with Synagis. These rare reactions may occur when any dose of Synagis is given, not just the first one. Also, rare but serious side effects can occur, which may lead to unusual bruising and/or groups of pinpoint red spots found on the skin.

Other side effects with Synagis may include upper respiratory tract infection, ear infection, fever, and runny nose. In children born with heart problems, Synagis was associated with reports of low blood oxygen levels and abnormal heart rhythms. Synagis should not be used in patients with a history of a severe prior reaction to Synagis or its components. Side effects, such as, skin reactions around the area where the shot was given (like redness, swelling, warmth, or discomfort) can also occur.

Privacy Policy | Terms and Conditions | Site Map